PROVIDER PROFILE · NPI 1023086758
Nina SoudersMD
PRESCRIBING · PART D · 2024
Total Rx claims
439
Beneficiaries
—
Total drug cost
$244K
Distinct drugs
14
Brand share
71.8%
Top prescribed drugs
Semaglutide92 claims
Empagliflozin52 claims
Rosuvastatin Calcium38 claims
Tirzepatide33 claims
Dulaglutide32 claims
QUALITY · MIPS · 2024
Final MIPS score
82.1
Quality
66.8
Cost
74.4
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.30%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$185
Payment records
8
By payment type
Food and Beverage$185
Top paying entities
Food and Beverage$185
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE